CPIX Logo

Cumberland Pharmaceuticals Inc. (CPIX) 

NASDAQ
Market Cap
$17.41M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
354 of 966
Rank in Industry
18 of 59

Largest Insider Buys in Sector

CPIX Stock Price History Chart

CPIX Stock Performance

About Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Insider Activity of Cumberland Pharmaceuticals Inc.

Over the last 12 months, insiders at Cumberland Pharmaceuticals Inc. have bought $27,287 and sold $0 worth of Cumberland Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at Cumberland Pharmaceuticals Inc. have bought $63,520 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Krogulski Kenneth (director) — $18,454. Jones James (director) — $3,582. KAZIMI A J (Chairman and CEO) — $3,582.

The last purchase of 75 shares for transaction amount of $99 was made by KAZIMI A J (Chairman and CEO) on 2024‑11‑29.

List of Insider Buy and Sell Transactions, Cumberland Pharmaceuticals Inc.

2024-11-29PurchaseChairman and CEO
75
0.0005%
$1.32$99-11.43%
2024-11-29Purchasedirector
474
0.0032%
$1.32$626-11.43%
2024-11-29Purchasedirector
75
0.0005%
$1.32$99-11.43%
2024-11-29Purchasedirector
16
0.0001%
$1.32$21-11.43%
2024-11-27PurchaseChairman and CEO
75
0.0005%
$1.15$86-9.12%
2024-11-27Purchasedirector
474
0.003%
$1.15$545-9.12%
2024-11-27Purchasedirector
75
0.0005%
$1.15$86-9.12%
2024-11-27Purchasedirector
16
<0.0001%
$1.15$18-9.12%
2024-11-26PurchaseChairman and CEO
75
0.0005%
$1.11$83+12.61%
2024-11-26Purchasedirector
474
0.0033%
$1.11$526+12.61%
2024-11-26Purchasedirector
75
0.0005%
$1.11$83+12.61%
2024-11-26Purchasedirector
16
0.0001%
$1.09$17+12.61%
2024-11-25PurchaseChairman and CEO
75
0.0005%
$1.09$82+17.45%
2024-11-25Purchasedirector
474
0.0035%
$1.09$517+17.45%
2024-11-25Purchasedirector
75
0.0005%
$1.09$82+17.45%
2024-11-25Purchasedirector
16
0.0001%
$1.09$17+17.45%
2024-11-22PurchaseChairman and CEO
75
0.0005%
$1.07$80+16.98%
2024-11-22Purchasedirector
474
0.0034%
$1.07$507+16.98%
2024-11-22Purchasedirector
75
0.0005%
$1.07$80+16.98%
2024-11-22Purchasedirector
16
0.0001%
$1.07$17+16.98%

Insider Historical Profitability

<0.0001%
KAZIMI A JChairman and CEO
5701527
40.6025%
$1.243301<0.0001%
Krogulski Kennethdirector
271627
1.9343%
$1.243460<0.0001%
Jones Jamesdirector
39377
0.2804%
$1.242250<0.0001%
Young Carolinedirector
29664
0.2112%
$1.243360<0.0001%
Greer Lawrence Wdirector
496435
3.5353%
$1.2402
Marstiller Jean WSr. VP & Corp. Secretary
428198
3.0493%
$1.2402
Edwards Robertdirector
400970
2.8554%
$1.2411<0.0001%
Cearnal Martin ESr VP/Chief Commercial Officer
178473
1.271%
$1.241720<0.0001%
JACOBS JOEY Adirector
88415
0.6296%
$1.24380<0.0001%
Galante Joseph Cdirector
57356
0.4085%
$1.243040<0.0001%
Pavliv LeoSr. Vice President, Operations
26445
0.1883%
$1.2411<0.0001%
Bonner MichaelChief Financial Officer
18454
0.1314%
$1.2490<0.0001%
Griggs Jonathandirector
10803
0.0769%
$1.2401
Hamm John M.Chief Financial Officer
6800
0.0484%
$1.2410+6.25%
Lawrence Thomas Rdirector
0
0%
$1.24016
Bernard Gordon Rdirector
0
0%
$1.24078

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Renaissance Technologies$912,000.003.82542,663-1.31%-$12,100.33<0.01
The Vanguard Group$628,742.002.64374,2510%+$0<0.0001
Dimensional Fund Advisors$600,793.002.52357,615-2.27%-$13,975.92<0.0001
Bridgeway Capital Management$481,580.002.02286,6550%+$00.01
Acadian Asset Management$315,000.001.33188,1640%+$0<0.01
BlackRock$185,748.000.78110,564-0.38%-$715.68<0.0001
Geode Capital Management$142,019.000.684,522-0.88%-$1,263.56<0.0001
BNY Mellon$126,450.000.5375,2680%+$0<0.0001
State Street$56,616.000.2433,700-15.3%-$10,231.20<0.0001
Two Sigma$54,482.000.2332,430-1.82%-$1,007.99<0.0001
Two Sigma Advisers LP$38,640.000.1623,000-1.71%-$672.00<0.0001
Northern Trust$27,448.000.1216,338-10.18%-$3,109.70<0.0001
Cresset Asset Management Llc$20,202.000.0912,0250%+$0<0.0001
Morgan Stanley$18,940.000.0811,2740%+$0<0.0001
Tower Research Capital$9,655.000.045,747+2.11%+$199.92<0.0001
Citadel Advisors LLC$6,085.000.033,622+2.46%+$146.16<0.0001
Oakworth Capital Inc$5,127.000.023,0520%+$0<0.0001
UBS$3,012.000.011,793+1,530%+$2,827.22<0.0001
Advisor Group Holdings Inc$168.00<0.01100New+$168.00<0.0001
Wells Fargo$109.00<0.0165+3.17%+$3.35<0.0001
Huntington National Bank$2.00<0.0110%+$0<0.0001
Royal Bank of Canada$0<0.0147-65.94%-$0<0.0001
JPMorgan Chase$34.00<0.0120+66.67%+$13.60<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.